On October 15 and 16, 2020, the HARMONY Alliance Community Members i.e. Partners, Patient Organizations and Associated Members meet for the virtual General Assembly.
The COVID-19 pandemic also has an impact on the physical meetings of the HARMONY Alliance between all community contacts. The 5th General Assembly is transferred into a full virtual edition. HARMONY will facilitate its Partners, Associated Members and Associated Partners to meet up and discuss progress of projects, new research objectives and various big data related activities.
The afternoon of October 15 and 16 are reserved for virtual updates and live discussions. Find more information below.
AGENDA: Download the setup of both afternoons >
TOPICS: General update on HARMONY, on all HARMONY Research Projects (in AML, ALL, CLL, MDS, MM, NHL), introduction on HARMONY PLUS, introductions on new Projects (MPN & COVID-19, Epidemiology of COVID-19 patients with HM, HARMONY for validation of the finding of machine learning analysis, MRD AML, CML.
REGISTRATION: Not a HARMONY Partner, HARMONY Patient Organization, HARMONY Associated Member or HARMONY PLUS Partner, but interested to attend? Send us an email >
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
